Search

everythinglearnresearchcommunity

for

Search:↓

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Staphylococcus epidermidis A/C strains are more antibiotic-resistant and infection-adapted, while B strains thrive in hair follicles.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Most E. coli in broiler chickens are resistant to multiple antibiotics.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

The drug combination significantly reduced epileptic drop attacks in patients.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Tadalafil and Finasteride may help treat aggressive melanoma.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Nanotechnology shows promise for better drug delivery and cancer treatment.